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Abstract
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare adrenal tumour causing corticotrophin-independent Cushing’s 
syndrome. It occurs mainly in children and young adults. The histological examination is characterised by small pigmented micronodules 
on the adrenal cortex. The diagnosis is most often seen in patients with Carney Complex, but it can also occur in isolation. We report 
a case of Carney Complex that was referred for adrenalectomy. The procedure was uneventful and the patient was well at discharge. The 
adrenal pathology showed numerous black nodules measuring less than 2mm in diameter. This feature was pathognomonic of primary 
pigmented nodular adrenocortical disease. (Pol J Endocrinol 2011; 62 (3): 268–270)
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Introduction
Primary pigmented nodular adrenocortical disease 
(PPNAD) is the main endocrine manifestation of Car-
ney Complex. , which is a multiple neoplasia syndrome 
caused by PRKAR1A gene mutation. The syndrome 
is characterised by cutaneous lentigines, myxoma, 
schwannomas and endocrinopathy [9]. It was first 
described in 1985 by J Aidan Carney and co-workers at 
the Mayo Clinic [2]. It has rarely been reported in South 
East Asia. Indeed, we can only find a single report on 
this condition [8]. 
We present the case of a young woman who was re-
ferred for bilateral adrenalectomy. Her adrenal histology 
revealed multiple pigmented micronodules that were 
suggestive of PPNAD. Genomic study was suggested, 
but the patient refused it.
Case report
The patient was a 23 year-old Chinese woman who 
worked as an accounts clerk. She was referred for 
bilateral adrenalectomy by a private endocrinologist. 
She had been on treatment for hypertension for the 
past three years. Her blood pressure was well control-
led with atenolol and nifedipine. She also complained 
of amenorrhoea for six months prior to this referral. 
She had noticed increasing numbers of freckles over 
her face and arms. She had no history of hirsutism or 
virilisation. She did not complain of proximal myopathy, 
weight gain or abdominal striae. Two of her elder sisters 
had been diagnosed with Cushing’s syndrome and had 
undergone bilateral adrenalectomy. Her eldest sister 
died of acute stroke at the age of 33. She denied taking 
traditional or over-the-counter medicine.
On examination, she had no cushingoid fea-
tures. Her blood pressure was 130/85 mmHg. Her pulse 
rate was 76 beats/minute. There was an absence of the 
stigmata of Cushing’s syndrome such as truncal obes-
ity, paper-thin skin, abdominal striae, buffalo’s hump, 
hyperpigmentation or proximal myopathy. Multiple 
freckles were noted on the face and arms. The praecor-
dium examination was normal and a murmur was not 
present. The examination of the breast was normal. The 
chest and abdominal examinations were unremarkable. 
The neurological examination was normal without any 
localising signs. Fundoscopy examination did not reveal 
papilloedema.
Her haematological investigations, including 
haemoglobin, leucocytes count, and platelet count, 
were normal. Serum electrolytes, glucose, creatinine, 
liver function test, fasting serum lipid, serum prolac-
tin and CA-125 were all normal. The early morning 
plasma cortisol was 329 nmol/L. However, the level 
of early morning plasma cortisol had been more than 
1,000 nmol/L when it was performed previously by the 
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private endocrinologist. The random plasma ACTH was 
undetectable (less than 10 pg/mL). The low dose dexam-
ethasone suppression test failed to suppress the adrenal 
cortical activity. A similar finding was found with high 
dose dexamethasone suppression test. The echocar-
diogram showed good left ventricular systolic func-
tion with normal cardiac chambers and an absence of 
atrial myxoma. Abdominal ultrasound showed multiple 
cystic lesions on both ovaries. CT scan of the abdomen 
revealed multiple bilateral micronodular adrenal hy-
perplasias. MRI of the brain showed a non-functioning 
pituitary incidentaloma. 
The immediate clinical diagnosis was adrenocorti-
cotrophic independent Cushing’s syndrome second-
ary to bilateral micronodular adrenal hyperplasia. She 
underwent adrenalectomy with partial re-implantation 
of the adrenal tissue over the left forearm. The proce-
dure was successful and she was discharged in a good 
condition after five days. She opted to be followed up 
by her private endocrinologist, and was discharged 
from our care. Her adrenal histological examination was 
reported as primary pigmented nodular adrenocortical 
disease. The hallmark of the histological examination is 
the presence of multiple black nodules less than 2 mm 
in diameter. (Figures 1AB, 2). A further genomic study 
to detect PRKAR1A was discussed, but the patient 
refused the test.
Discussion
Carney Complex is a familial multiple endocrine neo-
plasia syndrome that is characterised by cardiac and 
cutaneous myxoma, lentigines and endocrinopathy. It 
is an autosomal dominant disease. The disease has a fa-
milial pattern in approximately 50% of patients, while in 
others it appears sporadically [4]. The clinical diagnosis 
is made when there is at least one characteristic clinical 
finding associated with the disease in the presence of 
a family history of Carney Complex. In the absence of 
family history, there should be at least two characteristic 
clinical findings [10]. 
PPNAD is a rare cause of adrenocorticotrophic hor-
mone independent Cushing’s syndrome. Adrenocorti-
cotrophic hormone independent Cushing’s syndrome 
is observed in 25–30% of patients with Carney Complex 
[8]. It has a predilection towards children and young 
adults. The peak incidence in adults is in their 20s, as was 
our patient. This tumour is very rarely found in children 
under the age of four and rarely diagnosed in adults 
after the age of 40 [7]. It is estimated that the diagnosis 
is made in no more than 1% of patients with Cushing’s 
syndrome [1]. The name derives from the macroscopic 
appearance of the adrenals that is characterised by 
small pigmented micronodules in the adrenal cortex. 
The disease usually involves bilateral adrenals. The 
Figure 1AB. A. (H & E) ×10. B. (H & E) ×40. The pigmented nodules that found in the adrenal cortex of this patient. The adrenal 
gland is hyperplastic with a macronodule (6mm in diameter) seen. Numerous micro-nodules were seen and there was uniform proliferation 
of cells with foci of cytoplasmic clearing and arranged in compact nests
A B
Figure 2. Synaptophysin immunostain. The numerous blackish 
pigments found on the adrenal cortex of this patient with primary 
pigmented nodular adrenocortical disease
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diagnosis of PPNAD can be made in an asymptomatic 
patient by familial screening or personal screening for 
features associated with Carney Complex. 
Our patient was diagnosed based on her strong 
family history as well as increasing numbers of lentigi-
nes on her face and arms. The low dose and high dose 
dexamethasone suppression test confirmed the dia-
gnosis of ACTH independent Cushing’s syndrome. In 
addition, her abdominal CT scan further strengthened 
the diagnosis of PPNAD.
The disease can present in several ways. Our patient 
presented with increasing cutaneous lentigines over her 
face and arms. In addition, she had a strong family his-
tory of features related to Carney Complex. Therefore, 
she was screened for PPNAD confirmed by HDDST, and 
adrenal hyperplasia was also visualised on her abdomi-
nal CT scan . The diagnosis of Cushing’s syndrome in 
PPNAD is often difficult because hypercortisolism may 
progress slowly over many years or may be cyclical [5, 
6]. Cyclical hypercortisolism has been described in some 
patients with PPNAD. This could  explain the absence 
of cushingoid features in our patient. 
Cardiac and other cutaneous myxomas, spotty vel-
vety cutaneous pigmentation and endocrine tumours 
are the main characteristics of this disease. Cardiac 
myxoma is an important feature. Unrecognised cardiac 
myxoma may be the cause of sudden cardiac death due 
to thromboembolism. Although the echocardiographic 
examination was normal, our patient requires  close 
monitoring for the development of this tumour. Her 
eldest sister died due to acute stroke which could have 
been the result of a thrombotic event from an undetec-
ted cardiac myxoma. Cutaneous pigmentation is the 
commonest manifestation of the disease [10]. Lentigines 
are seen in most patients, and this characteristic mani-
festation can be used to make the definitive diagnosis 
[5]. Other common endocrine tumours include pituitary 
adenomas, thyroid adenomas and carcinoma, testicular 
tumours and ovarian tumours [5, 10]. 
In conclusion, the manifestations of Carney Complex 
can vary between patients. Lentigines are the main 
manifestation. The recognition of adrenal Cushing’s 
syndrome can be difficult in some patients with cycli-
cal hypercortisolism. Patients should also be screened 
for cardiac myxoma periodically to avoid sudden un-
expected death. In most cases, removal of the bilateral 
adrenal glands is required to demonstrate an apparent 
cure for the disease. Long term follow-up of this patient 
is mandatory to detect occurrence of other associated 
tumours. Awareness of the various components of 
the disease will help identify affected patients, as will 
screening of their first degree relatives.
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